ID   HOVTAX2
AC   CVCL_AV53
SY   HOV Tax2
DR   ABM; T8248
DR   Wikidata; Q54890191
RX   PubMed=22115851;
CC   Miscellaneous: This cell line was orginally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22115851
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 13,14
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
RX   PubMed=22115851; DOI=10.1016/j.ygyno.2011.11.019; PMCID=PMC3468155;
RA   Vishnu P., Colon-Otero G., Kennedy G.T., Marlow L.A., Kennedy W.P.,
RA   Wu K.J., Santoso J.T., Copland J.A. 3rd;
RT   "RhoB mediates antitumor synergy of combined ixabepilone and sunitinib
RT   in human ovarian serous cancer.";
RL   Gynecol. Oncol. 124:589-597(2012).
//